Generative Somatics
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$438,016
Cash & Equivalents
91%
Receivables (Non-Related)
8%
Other Assets
<1%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$26,526
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$577,547
$398,772
-31%
Receivables (Non-Related)
$9,826
$36,494
+271%
Related-Party Receivables
-
$0
-
Inventories
-
$0
-
Prepaid Expenses
$6,158
$0
-100%
Investments
-
$0
-
Property, Plant, & Equipment (net)
$2,912
$0
-100%
Other Assets
$68,568
$2,750
-96%
Total Assets
$665,011
$438,016
-34%
Liabilities
2023
2024
Change
Payables & Accruals
$8,497
$26,526
+212%
Grants Payable
-
-
-
Deferred Revenue
$77,500
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$74,580
-
-
Total Liabilities
$160,577
$26,526
-83%
Net assets
2023
2024
Change
Restricted Net Assets
$100,000
-
-
Unrestricted Net Assets
$404,434
$411,490
+2%
Net assets
2023
2024
Change
Net assets
+$504,434
+$411,490
-18%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)